Patterns of distant metastasis and survival outcomes in de novo metastatic breast cancer according to age groups

Front Endocrinol (Lausanne). 2024 May 1:15:1385756. doi: 10.3389/fendo.2024.1385756. eCollection 2024.

Abstract

Background: Is de novo metastatic breast cancer (dnMBC) the same disease in the elderly as in younger breast cancer remains unclear. This study aimed to determine the metastatic patterns and survival outcomes in dnMBC according to age groups.

Methods: We included patients from the Surveillance Epidemiology and End Results program. Chi-square test, multivariate logistic regression analyses, and multivariate Cox regression models were used for statistical analyses.

Results: A total of 17719 patients were included. There were 3.6% (n=638), 18.6% (n=3290), 38.0% (n=6725), and 39.9% (n=7066) of patients aged <35, 35-49, 50-64, and ≥65 years, respectively. Older patients had a significantly higher risk of lung metastasis and a significantly lower risk of liver metastasis. There were 19.1%, 25.6%, 30.9%, and 35.7% of patients with lung metastasis in those aged <35, 35-49, 50-64, and ≥65 years, respectively. Moreover, the proportion of liver metastasis was 37.6%, 29.5%, 26.3%, and 19.2%, respectively. Age was the independent prognostic factor associated with breast cancer-specific survival (BCSS) and overall survival (OS). Those aged 50-64 years had significantly inferior BCSS (P<0.001) and OS (P<0.001) than those aged <35 years. Patients aged ≥65 years also had significantly lower BCSS (P<0.001) and OS (P<0.001) than those aged <35 years. However, similar outcomes were found between those aged 35-49 and <35 years.

Conclusion: Our study suggests that different age groups may affect the metastatic patterns among patients with dnMBC and the survival of younger patients is more favorable than those of older patients.

Keywords: SEER; age; breast cancer; metastatic patterns; prognosis.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Breast Neoplasms* / mortality
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Liver Neoplasms* / mortality
  • Liver Neoplasms* / secondary
  • Lung Neoplasms* / mortality
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / secondary
  • Middle Aged
  • Neoplasm Metastasis
  • Prognosis
  • SEER Program
  • Survival Rate

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.